Identification of MDV and REV using RPA-CRISPR/Cas12a combined with fluorescence and lateral flow assays
Analytical Biochemistry · 2027
DOI: 10.1016/j.ab.2026.116240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Biochemistry, 2027. Verfasst von Ruiying Han und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, Guangxi University, Nanning, Guangxi, 530004, China. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Nucleic Acid Amplification Techniques, Reticuloendotheliosis virus, Herpesvirus 2, Gallid. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Natural Science Foundation of Guangxi Province.
Abstract (Originalsprache)
Marek's disease virus (MDV) and reticuloendotheliosis virus (REV) are two major immunosuppressive oncogenic viruses that severely threaten the global poultry industry. Field co-infection of these two pathogens is prevalent, accompanied by highly similar pathological lesions, making conventional diagnostic technologies incapable of rapid on-site differential identification. Recombinase polymerase amplification (RPA) coupled with the CRISPR/Cas12a system represents an innovative platform for rapid nucleic acid detection. In this study, target-specific crRNAs were designed against the conserved unique genes of MDV and REV, respectively, to establish a CRISPR-based diagnostic system capable of differentiating the two viruses for the first time. Comprehensive optimization of RPA reaction composition, buffer formulation and incubation temperature improved the overall detection performance. Three independent visual signal readout modalities were supported by this assay, including real-time fluorescence quantification, naked-eye fluorescence visualization under blue light, and lateral flow assay (LFA). Sensitivity evaluation demonstrated that the limit of detection (LOD) reached 1 × 10° copies/μL for MDV and 1 × 101 copies/μL for REV. Specificity assays verified that the system only generated specific positive signals in response to target viruses without cross-reactivity against other common avian oncogenic viruses and their subgroups. Blind testing of 30 clinical chick fecal specimens revealed that the assay achieved a 100% positive detection rate for both viruses when referenced to qPCR and RT-qPCR, with outstanding diagnostic efficacy and perfect detection consistency. Collectively, the developed RPA-CRISPR/Cas12a assay overcomes the limitations of traditional diagnostic methods and holds great promise for on-site routine screening in poultry farms and epidemiological surveillance of MDV and REV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Animal Science and Technology, Guangxi University, Nanning, Guangxi, 530004, China.
- Guangxi Academy of Sciences, Nanning, Guangxi, 530007, China.
- College of Animal Science and Technology, Guangxi University, Nanning, Guangxi, 530004, China; Guangxi Key Laboratory of Animal Breeding & Disease Control and Prevention, Guangxi University, Nanning, Guangxi, 530004, Ch…
Förderung
- Natural Science Foundation of Guangxi Province
Zitieren
APA
Han, R., Xiao, N., Wang, J., Wu, Z., Wang, X., & Tang, X. (2027). Identification of MDV and REV using RPA-CRISPR/Cas12a combined with fluorescence and lateral flow assays. Analytical Biochemistry. https://doi.org/10.1016/j.ab.2026.116240
Vancouver
Han R, Xiao N, Wang J, Wu Z, Wang X, Tang X. Identification of MDV and REV using RPA-CRISPR/Cas12a combined with fluorescence and lateral flow assays. Analytical Biochemistry. 2027. doi:10.1016/j.ab.2026.116240
BibTeX
@article{Han2027,
author = {Han, Ruiying and Xiao, Ning and Wang, Jiahua and Wu, Zhirui and Wang, Xiaoli and Tang, Xiaochuan},
title = {Identification of MDV and REV using RPA-CRISPR/Cas12a combined with fluorescence and lateral flow assays},
journal = {Analytical Biochemistry},
year = {2027},
doi = {10.1016/j.ab.2026.116240}
}
EUVIMED